Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,591 | 614 | 99.2% |
| Education | $87.68 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,636 | 69 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,190 | 27 | $0 (2022) |
| Novo Nordisk Inc | $939.53 | 60 | $0 (2024) |
| Lilly USA, LLC | $733.70 | 46 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $701.37 | 43 | $0 (2024) |
| PFIZER INC. | $658.70 | 52 | $0 (2024) |
| ABBVIE INC. | $563.52 | 33 | $0 (2024) |
| Astellas Pharma US Inc | $407.47 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $399.28 | 26 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $351.38 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,338 | 72 | Novo Nordisk Inc ($173.47) |
| 2023 | $1,137 | 66 | Lilly USA, LLC ($156.17) |
| 2022 | $1,643 | 86 | ABBVIE INC. ($227.67) |
| 2021 | $1,220 | 66 | AstraZeneca Pharmaceuticals LP ($184.53) |
| 2020 | $1,124 | 67 | AstraZeneca Pharmaceuticals LP ($200.34) |
| 2019 | $1,210 | 49 | AstraZeneca Pharmaceuticals LP ($220.36) |
| 2018 | $1,713 | 96 | Janssen Pharmaceuticals, Inc ($371.25) |
| 2017 | $2,294 | 115 | Janssen Pharmaceuticals, Inc ($527.44) |
All Payment Transactions
617 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: VACCINES | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: Genetic Disease | ||||||
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Cardio-renal | ||||||
| 11/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Biological | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Vaccines | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/17/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Cardio-renal | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: UROLOGY | ||||||
| 09/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: DIABETES | ||||||
| 09/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.28 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,331 | 1,962 | $163,869 | $96,212 |
| 2022 | 30 | 1,669 | 2,460 | $167,788 | $101,560 |
| 2021 | 33 | 1,928 | 2,599 | $170,763 | $107,614 |
| 2020 | 34 | 2,021 | 2,938 | $228,182 | $126,080 |
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 209 | 446 | $48,760 | $23,212 | 47.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 153 | 153 | $20,283 | $18,248 | 90.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 134 | $19,778 | $10,827 | 54.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 118 | $11,656 | $6,945 | 59.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 92 | 92 | $9,737 | $6,470 | 66.5% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 39 | 39 | $6,825 | $5,577 | 81.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 62 | $8,680 | $5,314 | 61.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 96 | 96 | $4,022 | $2,730 | 67.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 21 | $4,575 | $2,028 | 44.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 174 | 223 | $1,808 | $1,723 | 95.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $3,630 | $1,650 | 45.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 39 | 39 | $1,755 | $1,479 | 84.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 19 | 24 | $3,108 | $1,437 | 46.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $3,264 | $1,427 | 43.7% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 71 | 137 | $3,220 | $1,304 | 40.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 13 | 14 | $2,198 | $1,188 | 54.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 29 | 33 | $2,613 | $1,082 | 41.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $2,056 | $982.80 | 47.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 33 | 67 | $1,721 | $642.32 | 37.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 34 | 34 | $641.01 | $555.73 | 86.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 16 | 21 | $1,449 | $541.62 | 37.4% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 47 | 90 | $675.00 | $346.50 | 51.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 31 | 31 | $527.00 | $189.41 | 35.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 13 | 13 | $618.00 | $168.00 | 27.2% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 30 | 36 | $270.00 | $141.84 | 52.5% |
About Dr. Dennis Carter, MD
Dr. Dennis Carter, MD is a Family Medicine healthcare provider based in Murfreesboro, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831287630.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dennis Carter, MD has received a total of $11,679 in payments from pharmaceutical and medical device companies, with $1,338 received in 2024. These payments were reported across 617 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($11,591).
As a Medicare-enrolled provider, Carter has provided services to 6,949 Medicare beneficiaries, totaling 9,959 services with total Medicare billing of $431,467. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Murfreesboro, TN
- Active Since 10/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1831287630
Products in Payments
- FARXIGA (Drug) $1,072
- XARELTO (Drug) $712.70
- JARDIANCE (Drug) $566.23
- ENTRESTO (Drug) $556.21
- INVOKANA (Drug) $477.58
- Ozempic (Drug) $416.85
- XIFAXAN (Drug) $367.01
- ELIQUIS (Drug) $342.04
- BREZTRI (Drug) $302.40
- VRAYLAR (Drug) $266.06
- Rybelsus (Drug) $262.03
- UBRELVY (Drug) $237.60
- NUEDEXTA (Drug) $223.91
- BELSOMRA (Drug) $222.42
- TRINTELLIX (Drug) $211.03
- GEMTESA (Drug) $204.82
- CAPLYTA (Drug) $174.40
- Trintellix (Drug) $140.19
- SOLIQUA (Drug) $135.60
- ANORO (Drug) $135.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Murfreesboro
Dr. Scott Eller, M.d, M.D
Family Medicine — Payments: $18,623
Dr. Thomas Helton, Md, MD
Family Medicine — Payments: $15,111
Dr. Laura Born, Md, MD
Family Medicine — Payments: $13,627
Dr. Adam Childs, M.d, M.D
Family Medicine — Payments: $13,253
Nicholas Cote, D.o, D.O
Family Medicine — Payments: $10,359
Akashia Anderson, M.d, M.D
Family Medicine — Payments: $10,110